Unitaid, FIND, Liverpool School of Tropical Medicine Launch $30M Initiatives for Better TB Testing
The projects, called Drive Diagnostics for TB and START 4-ALL, aim to develop same-day assays for tuberculosis and better testing access for people at high risk.
FIND, Unitaid Sign $14.5M Deal to Evaluate NGS-Based Diagnosis of Drug-Resistant TB
The project, called Seq&Treat, will be implemented in Brazil, China, Georgia, India, and South Africa starting in October.
Pricing Agreement Expected to Broaden Access to Hologic Infectious Disease Tests
Public sector programs in some low- and middle-income countries will obtain access to Hologic's Panther system through a single, all-inclusive pricing structure.
Dx Focus: PEPFAR Funding Drives Cepheid TB Test Uptake; Curetis Starts US Trials for MDx System
The United States President's Emergency Plan for AIDS Relief, or PEPFAR, this week announced it would provide $11 million in funding for as many as 150 Cepheid GeneXpert systems and 450,000 MTB/RIF test cartridges in 14 high-burden countries in sub-Saharan Africa and Burma.
Cepheid said today that it has signed the first in a series of agreements with various government agencies and non-profit organizations to buy down the price of Cepheid's Xpert MTB/RIF test in a bid to drive widespread adoption of the assay in the developing world.